HPHA — Heidelberg Pharma AG Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Heidelberg Pharma AG, fiscal year end - November 30th, EUR millions except per share, conversion factor applied.

	2020 November 30th	2021 November 30th	2022 November 30th	2023 November 30th	2024 November 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-18.4	-26.1	-19.7	-20.3	-19.4
Depreciation
Non-Cash Items	0.754	1.2	0.496	-4.12	0.371
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1.01	-2.48	9.59	-10.1	-11.4
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-17.9	-26.6	-8.86	-33.7	-29.6
Capital Expenditures	-1.43	-1.39	-0.613	-0.96	-0.478
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.144	-0.013	0.015	6.81	0.029
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1.29	-1.4	-0.598	5.85	-0.449
Financing Cash Flow Items	-0.061	-0.749	-0.818	0	-1.58
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	14.3	29.2	84	-10.1	16.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-4.9	1.16	75.2	-37.9	-14